Innovex International, Inc.
Innovex International, Inc. Fundamental Analysis
Innovex International, Inc. (INVX) shows weak financial fundamentals with a PE ratio of 40.02, profit margin of 5.31%, and ROE of 5.03%. The company generates $1.0B in annual revenue with strong year-over-year growth of 48.04%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 61.4/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze INVX's fundamental strength across five key dimensions:
Efficiency Score
WeakINVX struggles to generate sufficient returns from assets.
Valuation Score
ModerateINVX shows balanced valuation metrics.
Growth Score
ModerateINVX shows steady but slowing expansion.
Financial Health Score
ExcellentINVX maintains a strong and stable balance sheet.
Profitability Score
WeakINVX struggles to sustain strong margins.
Key Financial Metrics
Is INVX Expensive or Cheap?
P/E Ratio
INVX trades at 40.02 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, INVX's PEG of -0.54 indicates potential undervaluation.
Price to Book
The market values Innovex International, Inc. at 2.01 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 10.67 times EBITDA. This signals the market has high growth expectations.
How Well Does INVX Make Money?
Net Profit Margin
For every $100 in sales, Innovex International, Inc. keeps $5.31 as profit after all expenses.
Operating Margin
Core operations generate 10.84 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $5.03 in profit for every $100 of shareholder equity.
ROA
Innovex International, Inc. generates $4.03 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Innovex International, Inc. produces operating cash flow of $179.19M, showing steady but balanced cash generation.
Free Cash Flow
Innovex International, Inc. generates strong free cash flow of $145.38M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $2.11 in free cash annually.
FCF Yield
INVX converts 7.03% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
40.02
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.54
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.01
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.12
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.07
vs 25 benchmark
Current Ratio
Current assets to current liabilities
5.10
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.05
vs 25 benchmark
ROA
Return on assets percentage
0.04
vs 25 benchmark
ROCE
Return on capital employed
0.09
vs 25 benchmark
How INVX Stacks Against Its Sector Peers
| Metric | INVX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 40.02 | 21.39 | Worse (Expensive) |
| ROE | 5.03% | 922.00% | Weak |
| Net Margin | 5.31% | -57637.00% (disorted) | Weak |
| Debt/Equity | 0.07 | -0.49 (disorted) | Distorted |
| Current Ratio | 5.10 | 5.04 | Strong Liquidity |
| ROA | 4.03% | -1987.00% (disorted) | Weak |
INVX outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Innovex International, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
36.95%
Industry Style: Cyclical, Value, Commodity
High GrowthEPS CAGR
238.33%
Industry Style: Cyclical, Value, Commodity
High GrowthFCF CAGR
562.57%
Industry Style: Cyclical, Value, Commodity
High Growth